-
Jim Cramer Says Thermo Fisher's CEO 'Does Not Fool Around' And Is 'One Of The Greats'
Friday, May 27, 2016 - 11:42am | 267Thermo Fisher Scientific Inc. (NYSE: TMO) announced on Friday it has agreed to acquire FEI Company (NASDAQ: FEIC) in a deal that values the scientific instruments company at $4.2 billion. The transaction was also the focus of CNBC's daily "The Mad Dash" segment. Cramer noted...
-
Barron's Recap: Work Is For Squares
Sunday, August 31, 2014 - 3:34pm | 875This weekend in Barron's online: the consequences of declining workforce participation, as well as the prospects for Thermo Fisher, USG, Synaptics and more. Cover Story "The Decline of Work" by Gene Epstein. While the job market has made a comeback over the past year, the...
-
Exclusive: Bio-Techne Executive On M&A Possiblities
Wednesday, July 16, 2014 - 10:59am | 498Bio-Techne (NASDAQ: TECH) announced the $60 million acquisition of Novus Biologicals earlier this month and the $300 million acquisition of ProteinSimple in June. In an exclusive interview with Benzinga, Director of Business Development Frank Mortari discussed M&A activity in the...
-
Top Performing Health Care Stocks in January
Wednesday, February 1, 2012 - 7:32am | 981Here's a quick look at some of the top performing health care stocks, year to date. These stocks all have a market cap of more than $1 billion and all pay a dividend. Baxter International (NYSE: BAX) is more than 11% higher than a month ago, and more than 17% higher than a year ago. The company...
-
Deutsche Bank Raises TMO Target From $74 To $75
Friday, February 25, 2011 - 9:47am | 28Deutsche Bank is raising its PT on shares of Thermo Fisher (NYSE: TMO) from $74 to $75. Thermo Fisher closed Thursday at $55.33.
-
President Obama's FY2012 Budget Details Released
Monday, February 14, 2011 - 10:21am | 244Deutsche Bank has published a research report on Healthcare Services & Technology after President Obama released details on his FY2012 budget this morning. In the report, Deutsche Bank writes "The budget is primarily focused on deficit reduction, but the budget for the NIH was actually provided...
-
Life Sciences Research From Jefferies
Monday, September 27, 2010 - 8:52am | 197Jefferies & Co. has published a research report for Life Sciences, reporting: "Median short interest for listed and OTC Life Science Research Supply stocks rose 1% from the second half of August, while aggregate short interest levels were essentially unchanged (vs. a 1% increase for Nasdaq and...